Announcement for The Global PNH Patient Registry

We are excited to announce that several new surveys are available within the Global PNH Patient Registry platform. Enroll in the Global PNH Patient Registry today or log back in to answer these quick and easy surveys about your experience with paroxysmal nocturnal hemoglobinuria. You may save as you go and complete the surveys at your own pace. PNH research moves forward when patients like you are involved! As a thank you, we have also introduced a new program so that eligible participants who complete all of the baseline surveys may select to receive a digital gift card totaling $75 USD. Please note, gift cards may take up to 6-8 weeks to process once selected and participant eligibility is reviewed and confirmed. To learn more about the Thank You Gift Cards, please review the Frequently Asked Questions (FAQ).

AAMDSIF Provides Services and Resources for People with PNH

The Aplastic Anemia and MDS International Foundation (AAMDSIF) is the world’s leading nonprofit health organization dedicated to supporting patients and families living with aplastic anemia, myelodysplastic syndrome (MDS), paroxysmal nocturnal hemoglobinuria (PNH), and related bone marrow failure diseases. AAMDSIF provides answers, support, and hope to thousands of patients and their families around the world.

We are a patient-focused, patient-centered organization, serving patients and families throughout the three phases of bone marrow failure diseases:

  • the life changing phase of diagnosis
  • the life-threatening phase of treatment
  • the life-long phase of living with a chronic disease

AAMDSIF Programs and Services include:

  • Patient and family conferences
  • Webinars
  • Patient education materials in print and digital formats
  • Patient support groups and peer support network

For more information about PNH or AAMDSIF, call (800) 747-2820 or visit

Webinar: Advancing Research Through the Global PNH Patient Registry

Date: May 12, 2021

Time: 1:00 - 2:00 pm ET

Register here


The Global PNH Patient Registry is a collaborative effort between the Aplastic Anemia and MDS International Foundation (AAMDSIF), industry sponsors and the National Organization for Rare Disorders (NORD) to study paroxysmal nocturnal hemoglobinuria (PNH). It supports research, provides insight on treatment for the PNH community and helps understand the progression of PNH over time. Join us for this webinar to learn more about this patient registry.


The Global PNH Patient Registry

We are pleased to announce the launch of the Global PNH Patient Registry, a collaborative effort between the Aplastic Anemia and MDS International Foundation (AAMDSIF) and the National Organization for Rare Disorders (NORD®) to study PNH.

Overview of Research Study

The Global PNH Patient Registry is more than a versatile online system that securely collects and stores data for medical research; it is an interactive dynamic participant-driven resource that can empower and unite the PNH community through shared knowledge. Registry participants not only can complete surveys about their own disease experiences, but also can learn about other participants’ experiences by viewing aggregated survey data. As the registry sponsor,* AAMDSIF will ensure that data privacy and confidentiality are strictly maintained. Participation in the Global PNH Patient Registry is free and voluntary, and participants may withdraw at any time. The Global PNH Patient Registry will include data collection on demographics, quality of life, treatment, diagnosis, and PNH symptoms. It can be completed in stages throughout the course of the study.

Community Involvement

The Global PNH Patient Registry is a powerful opportunity for individuals with PNH and their family members to contribute directly to research that will enhance our understanding of PNH, thus facilitating the development of new diagnostic and treatment options. Participation is especially vital given the rarity of PNH. Every patient experience is a unique and invaluable part of the natural history of PNH.